Who invested in Rempex Pharmaceuticals?
Rempex Pharmaceuticals's investors include OrbiMed, Adams Street Partners, SV Life Sciences, Frazier Healthcare Partners and Vivo Ventures.
United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$68Mraised across 1 round since 2011, from 1 source
From historical deal records. Wrong? Tell us.
Rempex Pharmaceuticals's investors include OrbiMed, Adams Street Partners, SV Life Sciences, Frazier Healthcare Partners and Vivo Ventures.
Rempex Pharmaceuticals has raised $68M across 1 round since 2011.
Rempex Pharmaceuticals's most recent round was a Series B of $68M in Nov 2011.
Its most recent round, $68M in Nov 2011, is also its largest on record.
Rempex Pharmaceuticals's first round on record, in Nov 2011, was backed by OrbiMed, Adams Street Partners and SV Life Sciences and 2 others.
Rempex Pharmaceuticals's latest named round is a Series B, in Nov 2011.
Rempex Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.